Chargement en cours...
Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment
The prevalence of non-alcoholic fatty liver disease (NAFLD) is estimated to be 25-30% of the population, and is the most common cause of elevated liver enzymes in Korea. NAFLD is a “hot potato” for pharmaceutical companies. Many clinical trials are underway to develop a first-in-class drug to treat...
Enregistré dans:
| Publié dans: | Clin Mol Hepatol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
The Korean Association for the Study of the Liver
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5066376/ https://ncbi.nlm.nih.gov/pubmed/27729634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2016.0049 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|